Class Action Signal

Class Action Signal

Class ActionsNews
Class ActionsNewsAboutContact
Public case information

Immutep Securities Class Action

Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.

Immutep · Immutep securities · New Filing

Last updated

About this case

A securities class action has been filed against Immutep and certain of its officers and directors alleging securities fraud or other unlawful business practices affecting investors in the company. The matter is at the filing stage.

Case overview

Defendant company
Immutep
Product or service
Immutep securities
Court case number
1:26-cv-03705
Case status
New Filing
Lawsuit type
Securities
Reported harm
Misrepresentation

Important dates

Lead Plaintiff Application

Participation information

Availability is based on each listed participation option and its deadline.

Lead Plaintiff Application

The article states that the action was brought on behalf of Immutep investors, but does not provide further eligibility details.

Ask the court to be appointed lead plaintiff by the stated deadline.

Type
Lead Plaintiff
Status
Deadline passed

Immutep Investor Legal Rights Inquiry

The law firm invites individuals who purchased or acquired Immutep American Depositary Receipts between March 24, 2025, and March 12, 2026, to discuss their legal rights.

Contact Bragar Eagel & Squire, P.C. at (212) 355-4648 to discuss participation or legal rights.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Rosen Law Firm investor inquiry

Purchasers of Immutep American Depositary Receipts during the stated class period may be included in the proposed class, but eligibility details are not specified in the available content.

Type
Law Firm Signup
Status
Unknown
Reported proof requirement
Unclear

Immutep Investor Inquiry

Investors are invited to contact Bronstein, Gewirtz & Grossman regarding the securities class action.

Contact Bronstein, Gewirtz & Grossman using the contact information provided in the article.

Type
Law Firm Signup
Status
Unknown

Pomerantz investor inquiry

Investors with losses on their investment in Immutep are invited to contact Pomerantz LLP regarding the lawsuit.

Contact Danielle Peyton by email at newaction@pomlaw.com or by telephone at 646-581-9980 or 888-4-POMLAW, extension 7980. Email inquiries are encouraged to include a mailing address, telephone number, and number of shares purchased.

Type
Law Firm Signup
Status
Unknown

This information does not determine whether you qualify for a case.

Sources

Public reporting associated with this case.